Buprenorphine-based medication for opioid use disorder is associated with reduced stimulant use during pregnancy. // American Journal of Obstetrics & Gynecology MFM. – URL: https://www.sciencedirect.com/science/article/pii/S2589933326002429?dgcid=rss_sd_all
Buprenorphine-based medication for opioid use disorder is associated with reduced stimulant use during pregnancy. American Journal of Obstetrics & Gynecology MFM. https://www.sciencedirect.com/science/article/pii/S2589933326002429?dgcid=rss_sd_all
“Buprenorphine-based medication for opioid use disorder is associated with reduced stimulant use during pregnancy.” American Journal of Obstetrics & Gynecology MFM.
@article{article34439,
title = {Buprenorphine-based medication for opioid use disorder is associated with reduced stimulant use during pregnancy},
journal = {American Journal of Obstetrics \& Gynecology MFM},
url = {https://www.sciencedirect.com/science/article/pii/S2589933326002429?dgcid=rss_sd_all}
}